<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045259">
  <TermName>trimetrexate glucuronate</TermName>
  <TermPronunciation>(TRY-meh-TREK-sayt gloo-KYOO-roh-nayt)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that belongs to the family of drugs called antimetabolites. It is used in the treatment of pneumocystis carinii pneumonia and is being studied in the treatment of cancer.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000730848" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;trimetrexate glucuronate&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000730849" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;glucoronato de trimetrexato&quot;" language="es" id="_4"/>
  <SpanishTermName>glucoronato de trimetrexato</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>
      Medicamento que es un tipo de antimetabolito. Se usa para tratar la neumonía por 
      <ForeignWord>Pneumocystis carinii</ForeignWord>
       y está en estudio para el tratamiento del cáncer.
    </DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
</GlossaryTerm>
